Import/Export Declaration for List I and List II Chemicals

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
Form 486 Import/Export Declaration for List I and List II Chemicals	Form	Modified	Available
Form 486A Import Declaration for Ephedrine, Pseudoephedrine and Phenylpropanolamine	Form	Modified	Available
1117-0023 Supporting Statement DEA Form 486-486A (Final) 8-2-17.rtf	Supporting Statement A	Uploaded 2017-08-02	Available
Create Screenshot New DEA 486a (Import).pdf	Supplementary Document	Uploaded 2017-06-16	Available
Create Screenshot New DEA 486a (Import).pdf	Supplementary Document	Uploaded 2017-06-16	Available
DEA Online Import-Export Applcation Introduction and Overview.pdf	Supporting Statement B	Uploaded 2017-06-16	Available
21 U.S.C. 830.doc	Supplementary Document	Uploaded 2008-11-20	Available

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
12323	Import/Export Declaration for List I and List II Chemicals (Year)	Form	Modified	Import/Export Declaration for List I and List II Chemicals
12323	Import/Export Declaration for List I and List II Chemicals (Year)	Instruction	Modified
12323	Import/Export Declaration for List I and List II Chemicals (Year)	Form	Modified	Import Declaration for Ephedrine, Pseudoephedrine and Phenylpropanolamine

ICR Details

OMB Control No: 1117-0023	ICR Reference No: 201706-1117-001
Status: Historical Inactive	Previous ICR Reference No: 201605-1117-004
Agency/Subagency: DOJ/DEA	Agency Tracking No:
Title: Import/Export Declaration for List I and List II Chemicals
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Improperly submitted and continue	Conclusion Date: 08/02/2017
Retrieve Notice of Action (NOA)	Date Received in OIRA: 08/02/2017
Terms of Clearance:

table that charts list comparision

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	11/30/2019	36 Months From Approved	11/30/2019
Responses	13,661	0	13,661
Time Burden (Hours)	4,422	0	4,422
Cost Burden (Dollars)	242,781	0	242,781

---

Abstract: The DEA import/export declarations (DEA Forms 486 and 486A), will be replaced with an electronic process. Upon receipt of a complete declaration through the Diversion Control Division secure network application, DEA will provide the importer or exporter with the notice of receipt that must then be filed with Custom Border Patrol as part of the CBP import or export filing through Automated Commercial Environment (ACE), or any successor system. DEA will also transmit the declaration information electronically to CBP so that customs officers can validate importations and exportations subject to DEA regulations. Because of the requirement that regulated persons submit reports of regulated transactions in Listed chemicals to the DEA, the DEA is requiring such domestic regulated transaction reports to be submitted through the DEA Diversion Control Division secure network application, in addition to import and export regulated transactions. Mandatory reporting requirements for domestic regulated transactions are included as part of this rule because it allows for the DEA to create, at one time, an efficient, streamlined reporting structure of regulated activities applicable to tableting and encapsulating machines. As part of the implementation of the International Trade Data System (ITDS), the DEA is mandating electronic filing of return information for any person who desires to import non-narcotic substances in schedules III, IV, and V or to export non-narcotic substances in schedules III and IV and any other substance in schedule V, to furnish a controlled substances import declaration/controlled substance export invoice on DEA Forms 486 and 486A

---

Authorizing Statute(s): US Code: 21 USC 971 Name of Law: ...importation and exportation of listed chemicals
  

Citations for New Statutory Requirements: PL: Pub.L. 109 - 177 721 Name of Law: Combat Methamphetamine Act

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
1117-AB41	Proposed rulemaking	81 FR 63576	09/15/2016

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	81 FR 63576	09/15/2016
30-day Notice:	Federal Register Citation:	Citation Date:
	81 FR 96992	12/30/2016
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

table that charts list of burden

IC Title	Form No.	Form Name
Import/Export Declaration for List I and List II Chemicals (Year)	486, 486A	Import Declaration for Ephedrine, Pseudoephedrine and Phenylpropanolamine ,   Import/Export Declaration for List I and List II Chemicals

---

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $515,721

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 08/02/2017

---